<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To analyze the risk factors in the development of <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We retrospectively analyzed the characteristics of <z:mp ids='MP_0005048'>thrombosis</z:mp> in 61 APS patients </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical and laboratory parameters such as sex, age, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, smoking, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> and anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies were investigated to find out the risk factors of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:mp ids='MP_0005048'>Thrombosis</z:mp> was found in 70.49% APS patients, of whom, the prevalence of arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> were 36.67% and 39.34%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002625'>Deep vein thrombosis</z:hpo> of lower extremity (37.7%) and <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (24.59%) were the most common <z:mp ids='MP_0005048'>thrombosis</z:mp> events, and then <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e> and renal artery <z:mp ids='MP_0005048'>thrombosis</z:mp> were also common in APS patients </plain></SENT>
<SENT sid="5" pm="."><plain>The positive anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody and <z:hpo ids='HP_0000822'>hypertension</z:hpo> were the independent risk factors for venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody is associated with a higher risk of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> is associated with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
</text></document>